24/11/2014 13:02:23 Free Membership Login

Allergy Therapeutics Company Financial Information

 Company name: Allergy Thera.
 EPIC: AGY Trading Currency: GBX
 Market Sector: AIM ISIN: GB00B02LCQ05
 Market Segment: AIM Share Type: DE
 WWW Address:  Description: ORD 0.1P
 Industry Sector: PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Ask Open High Low Volume
 23.25 mages.advfn.com/imagesnew/2/us/down -0.75 [-3.12] 22.50 24.00 24.00 24.00 23.25 71,512
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 95.34 410.06 0.19 0.16 - 145.31 - 32.75 - 7.25

Allergy Therapeutics Key Figures

(at previous day's close)
Market Cap.95.34m
Shares In Issue410.06m
Prev. Close24.00
PE Ratio145.31 
Dividend Yield-%
EPS - basic0.16p
Dividend PS-p
Dividend Cover- 
Cash Flow PS0.53p
Return On Equity (ROE)4.92%
Operating Margin2.58%
PEG Factor6.30 
EPS Growth Rate23.08%
Dividends PS Growth Rate-%
Net Debt11.29m
Gross Gearing46.92%
Quick Assets7.57m
Net Working Capital7.57m
Intangibles / Fixed Assets26.26%
Turnover PS10.23p
Pre-Tax Profit PS0.26p
Retained Profit PS0.18p
Cash PS0.49p
Net Cash PS-1.08p
Net Tangible Asset Value PS *2.76p
Net Asset Value PS3.68p
Spread1.50 (6.25%) 

Allergy Therapeutics Balance Sheet

LSE:AGY:Liabilities+EQLSE:AGY:Assets

Allergy Therapeutics Share Price

Sample Period HighLow
1 week25.0018.75
4 weeks25.0018.63
12 weeks26.0017.75
1 year32.757.25

Allergy Therapeutics Share Price (5 years)

Allergy Therapeutics Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week18.754.5024.0021.300.1522.22
4 weeks18.754.5024.0019.590.0820.48
12 weeks23.75-0.50-2.1121.220.1022.20
26 weeks19.134.1321.5719.740.1119.87
1 year7.3815.88215.2517.240.3318.20
3 years10.5012.75121.4312.610.4411.97
5 years15.008.2555.0012.130.3411.81

Allergy Therapeutics Key Management Ratios

Allergy Therapeutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio30.86 
PE Ratio145.31 
Tobin's Q Ratio 3.32 
Tobin's Q Ratio (excl. intangibles)3.84 
Dividend Yield-%
Market-to-Book Ratio6.32 
Price-to-Pre-Tax Profit PS87.95 
Price-to-Retained Profit PS128.66 
Price-to-Cash Flow PS43.87 
Price-to-Sales PS2.27 
Price-to-Net Tangible Asset Value PS8.43 
Price-to-Cash PS46.99 
Net Working Capital PS1.85 
Price Pct to Working Capital PS12.60%
Earnings Yield0.69%
Average PE64.55 
Years in average4 
PE to PE average225.11%

Allergy Therapeutics Financial Ratios

(Leverage Ratios)
Debt Ratio31.24%
Debt-to-Equity Ratio0.45 
Debt-to-Equity Ratio (excl. Intgbl)0.61 
Debt-to-Equity Market Value0.07 
Net Gearing39.77%
Net Gearing (excl. Intangibles)45.86%
Gross Gearing46.92%
Gross Gearing (excl. Intangibles)54.10%
Gearing Under 1 Year22.80%
Gearing Under 1 Year (excl. Intgbl)26.29%
Assets/Equity1.88 
Cash/Equity13.46 
(Liquidity Ratios)
Net Working Capital to Total Assets26.64%
Current Ratio2.17 
Quick Ratio (Acid Test)1.17 
Liquidity Ratio0.31 
Cash & Equiv/Current Assets14.45%
(Solvency Ratios)
Enterprise Value100.16m
CFO/Sales0.05 
CFO/Attributable Profit2.93 
CFO/Assets0.08 
CFO/Debt0.16 
Total Debt/Equity Market Value0.14 
Total Debt/Sales0.32 
Total Debt/Pre-Tax Profit12.29 
Total Debt13.32m
Total Debt/Net Current Assets1.76%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs4 
Beta (60-Mnth)Beta (36-Mnth)
0.18690.6988
Alpha (60-Mnth)Alpha (36-Mnth)
0.01990.0299

Allergy Therapeutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)4.94%
Return On Assets (ROA)2.58%
Net Profit Margin1.77%
Assets Turnover1.46 
Return On Equity (ROE)4.92%
Return On Investment (ROI)3.43%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio4.98%
Net Income Of Revenues1.77%
(Asset Utilisation Multiples)
Shareholders Equity Turnover2.82 
Fixed Assets Turnover2.93 
Current Assets Turnover2.92 
Net Working Capital Turnover 
Inventory Turnover6.72 
(Other Operating Ratios)
Total Assets-to-Sales0.68 
Debtors-to-Sales15.41%
Debt Collection Period56.23Days

Allergy Therapeutics Dividends

Sorry No Data Available

Allergy Therapeutics Fundamentals

 30 Jun 2011 (GBP)30 Jun 2012 (GBP)30 Jun 2013 (GBP)30 Jun 2014 (GBP)
turnover41.55100.00%41.28100.00%39.28100.00%41.96100.00%m
pre tax profit-2.31-5.57%0.641.55%0.431.10%1.082.58%m
attributable profit-2.66-6.41%0.821.99%0.541.36%0.741.77%m
retained profit-2.66-6.41%0.821.99%0.541.36%0.741.77%m
eps - basic-0.86 0.25 0.13 0.16 
eps - diluted-0.86 0.24 0.13 0.16 
dividends per share- - - - 

Allergy Therapeutics Balance Sheet

 30 Jun 2011 (GBP)30 Jun 2012 (GBP)30 Jun 2013 (GBP)30 Jun 2014 (GBP)
LSE:AGY:Liabilities+EQLSE:AGY:AssetsLSE:AGY:Liabilities+EQLSE:AGY:AssetsLSE:AGY:Liabilities+EQLSE:AGY:AssetsLSE:AGY:Liabilities+EQLSE:AGY:Assets
 30 Jun 2011 (GBP)30 Jun 2012 (GBP)30 Jun 2013 (GBP)30 Jun 2014 (GBP)
ASSETS
fixed assets fixed assets8.8128.77%7.5627.22%7.3425.33%7.0324.76%m
intangibles intangibles4.4114.39%4.6016.56%3.9113.50%3.7713.28%m
fixed investments fixed investments2.498.14%2.579.26%3.0610.57%3.5612.53%m
current assets - other current assets - other--%0.481.74%--%--%m
stocks stocks6.7822.14%6.6523.96%6.0120.76%6.4722.78%m
debtors debtors7.0923.14%5.0018.00%7.3925.50%5.5419.52%m
cash & securities cash & securities1.053.42%0.903.25%1.264.34%2.037.14%m
TOTAL30.62100%27.75100%28.96100%28.40100%m
LIABILITIES
creditors - short creditors - short11.1536.40%7.7527.91%7.6226.31%6.4722.80%m
creditors - long creditors - long17.3456.61%5.4219.51%6.6723.04%6.8524.12%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL28.4893.01%13.1647.42%14.2949.35%13.3246.92%m
EQUITY
ord cap, reserves ord cap, reserves2.146.99%14.5952.58%14.6750.65%15.0853.08%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL2.146.99%14.5952.58%14.6750.65%15.0853.08%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Allergy Therapeutics Cash Flow Statement

30 Jun 2011 (GBP)30 Jun 2012 (GBP)30 Jun 2013 (GBP)30 Jun 2014 (GBP)
Operating CF-2.032.882.432.17m
Pre-Financing CF-4.311.311.281.04m
Retained CF-3.55-1.421.421.04m

Allergy Therapeutics Brokers

NameActivityTypeMnemonicCode
Nomura Code Securities LimitedMarket Maker(MMF)Broker/DealerCODECODCGB21
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MMF)Broker/DealerCANAHOARGB21001
Jefferies International LtdMarket Maker(MMF)Broker/DealerJEFFJEFFGB2X
Liberum Capital LimitedMarket Maker(MMF)Broker/DealerLIBCLCAPGB21
Piper Jaffray LtdMarket Maker(MMF)Broker/DealerPIPRPIPRGB21
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us lse agy141124 13:02